Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events 🔗 Access full article via Journal for ImmunoTherapy of CancerShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
